SEATTLE, Feb. 9 /PRNewswire-FirstCall/ -- Pacific Biomarkers, Inc. , which provides specialty reference biomarker services to support pharmaceutical and laboratory diagnostic manufacturers in the conduct of human clinical research, today announced that it has scheduled an investor conference call for 11:15 a.m. EST (8:15 a.m. PST) on Friday, February 12, 2010 to review the Company’s operating results for the second quarter and first half of FY2010. The Company intends to report its operating results prior to the conference call.
Investor Conference Call
About Pacific Biomarkers, Inc. (PBI)
PBI is headquartered in Seattle, Washington, and its common stock trades on the OTC Bulletin Board under the symbol “PBME”. For more information about PBI, visit the company’s web site at www.pacbio.com.
CONTACT: Ronald R. Helm, Chairman & CEO, Pacific Biomarkers, Inc.,
+1-206-298-0068; or RJ Falkner & Company, Inc., Investor Relations Counsel,
+1-830-693-4400, info@rjfalkner.com for Pacific Biomarkers, Inc.
Web site: http://www.pacbio.com//
